Ranivisio
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ranivisio, covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: EMA Authorised: Ranivisio (ranibizumab) — Midas Pharma GmbH
1 regulatory and trial event tracked for Ranivisio, covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: EMA Authorised: Ranivisio (ranibizumab) — Midas Pharma GmbH